Capital Research Global Investors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-390,678
| Closed | -$87.5M | – | 477 |
|
|
2025
Q1 | $87.5M | Buy |
390,678
+167,468
| +75% | +$37.5M | 0.02% | 298 |
|
|
2024
Q4 | $73.1M | Buy |
223,210
+63,017
| +39% | +$20.6M | 0.02% | 331 |
|
|
2024
Q3 | $48.1M | Buy |
+160,193
| New | +$48.1M | 0.01% | 343 |
|
|
2022
Q4 | – | Sell |
-494,732
| Closed | -$122M | – | 459 |
|
|
2022
Q3 | $122M | Buy |
494,732
+97
| +0% | +$23.9K | 0.04% | 245 |
|
|
2022
Q2 | $150M | Buy |
494,635
+155
| +0% | +$46.9K | 0.05% | 244 |
|
|
2022
Q1 | $203M | Sell |
494,480
-110,279
| -18% | -$45.3M | 0.05% | 237 |
|
|
2021
Q4 | $284M | Sell |
604,759
-56,636
| -9% | -$26.6M | 0.06% | 218 |
|
|
2021
Q3 | $281M | Sell |
661,395
-264
| -0% | -$112K | 0.07% | 217 |
|
|
2021
Q2 | $238M | Buy |
661,659
+802
| +0.1% | +$288K | 0.06% | 230 |
|
|
2021
Q1 | $186M | Sell |
660,857
-70,282
| -10% | -$19.8M | 0.05% | 253 |
|
|
2020
Q4 | $207M | Sell |
731,139
-149,910
| -17% | -$42.5M | 0.05% | 244 |
|
|
2020
Q3 | $242M | Sell |
881,049
-126,170
| -13% | -$34.7M | 0.07% | 198 |
|
|
2020
Q2 | $229M | Sell |
1,007,219
-290,319
| -22% | -$66M | 0.07% | 198 |
|
|
2020
Q1 | $198M | Sell |
1,297,538
-140,591
| -10% | -$21.4M | 0.08% | 189 |
|
|
2019
Q4 | $216M | Buy |
1,438,129
+1,216
| +0.1% | +$183K | 0.06% | 207 |
|
|
2019
Q3 | $204M | Buy |
1,436,913
+79
| +0% | +$11.2K | 0.07% | 206 |
|
|
2019
Q2 | $180M | Buy |
1,436,834
+967
| +0.1% | +$121K | 0.06% | 215 |
|
|
2019
Q1 | $158M | Buy |
1,435,867
+534,749
| +59% | +$58.9M | 0.05% | 228 |
|
|
2018
Q4 | $88.3M | Buy |
+901,118
| New | +$88.3M | 0.03% | 270 |
|